Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesImricor Medical Systems Inc

Imricor Medical Systems Inc

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
1.28 AUD -0.03 ( 2.29%)
Last update at 2026-11-06T05:10:00Z
VOLUME
260440
Market Cap
4370.95M

Momentum Score

…

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company's products include Vision-MR Ablation Catheter 2.0, a MR-compatible cardiac ablation catheter; Vision-MR Diagnostic Catheter, a MR-compatible diagnostic catheter; NorthStar mapping system, a real-time, high-resolution soft tissue imaging of MRI to guide and visualize procedures with exceptional clarity; and Advantage-MR EP Recorder / Stimulator. The company through its Imricor Cardiovascular vertical provides integrated single session workflows for hospitals for MR imaging. It also offers Vision-MR Dispersive Electrode to minimize eddy currents induced on the device's conductive pads during MR scanning. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
1.27
Low
1.31
High
52 Week Price Range
1.25
Low
2.25
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Imricor Medical Systems develops and commercializes MRI-compatible equipment and catheters for cardiac electrophysiology, enabling MRI-guided catheter ablation procedures. The company may benefit from rising atrial fibrillation prevalence, a broader shift toward image-guided minimally invasive therapies, and potential expansion if regulatory clearances and clinical adoption progress, which could support longer-term revenue growth and market penetration.
Key risks include uncertain clinical adoption and reimbursement, regulatory and competitive pressures from established electrophysiology device makers, and execution and financing challenges common to smaller medical‑technology companies.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
1.31
Dividend Yield
-
Revenue TTM
0.12M
Revenue Per Share
-
Gross Profit TTM
-2.79M
Debt / Equity
2.31
ROE
-143.12%
Net Debt
7.10M
ROCE
-83.03%
Diluted EPS TTM
-0.16

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -26.20M -29.69M -22.63M -17.36M -19.73M
Net income -26.20M -29.69M -22.63M -17.53M -20.56M
Selling general administrative - 4.92M 5.09M 4.98M 5.82M
Selling and marketing expenses - 2.27M 2.73M 2.80M 2.87M
Gross profit -2.10M -0.92M -1.12M -1.53M -1.90M
Reconciled depreciation - 0.75M 0.71M 0.71M 0.69M
Ebit -23.59M -16.30M -22.58M -17.18M -19.62M
Ebitda -22.56M -15.55M -21.87M -16.47M -18.93M
Depreciation and amortization 1.03M 0.75M 0.71M 0.71M 0.69M
Operating income -23.59M -16.30M -16.86M -17.18M -19.62M
Other operating expenses 23.89M 17.26M 17.47M 18.81M 21.74M
Interest expense 0.00M 0.02M 0.05M 0.18M 0.11M
Tax provision - 0.00M 0.00M 0.00M 0.00M
Interest income - 0.26M 0.06M 0.11M 0.02M
Net interest income - 0.24M 0.02M -0.07M -0.09M
Income tax expense - - -0.00M 0.18M 0.82M
Total revenue 0.30M 0.96M 0.62M 0.82M 0.70M
Total operating expenses 21.48M 15.37M 15.74M 16.47M 19.15M
Cost of revenue 2.41M 1.88M 1.73M 2.34M 2.59M
Total other income expense net -2.62M -13.40M -5.77M -0.18M -0.11M
Net income from continuing ops - -29.69M -22.63M -17.36M -19.73M
Net income applicable to common shares - -29.69M -22.63M -17.36M -19.73M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 45.79M 21.62M 12.18M 13.70M 26.86M
Other current assets 0.80M 0.79M 1.52M 1.59M 1.51M
Total liab 34.26M 29.00M 25.00M 6.19M 4.46M
Total stockholder equity 11.53M -7.38M -12.83M 7.51M 22.40M
Other current liab 4.78M 1.55M 1.16M 0.02M 0.18M
Common stock 0.03M 0.03M 0.02M 97.47M 95.01M
Capital stock - - - 97.47M 95.01M
Retained earnings -167.71M -142.28M -165.00M -89.96M -72.60M
Other liab - - - 0.54M 0.51M
Other assets - - - 0.23M 0.57M
Cash 19.52M 15.71M 1.22M 5.69M 18.52M
Total current liabilities 17.38M 2.36M 6.70M 2.07M 2.74M
Current deferred revenue 0.03M - 0.85M 0.92M 1.35M
Net debt 7.10M 5.51M 14.48M -1.20M -16.78M
Short term debt 12.07M 0.47M 1.60M 0.87M 0.52M
Short long term debt total 26.62M 21.21M 15.70M 4.49M 1.74M
Other stockholder equity 179.21M 134.88M 152.15M - -
Property plant equipment - - - 3.56M 3.60M
Total current assets 42.95M 18.35M 5.77M 9.68M 22.70M
Net tangible assets - - - 7.51M 22.40M
Short term investments 21.29M - - - -
Net receivables 0.24M 0.35M 0.58M 0.13M 0.09M
Long term debt - - - 2.18M -
Inventory 1.10M 1.50M 2.46M 2.28M 2.58M
Accounts payable 0.50M 0.33M 3.08M 0.26M 0.69M
Non currrent assets other 0.48M 0.68M 1.49M 0.46M 0.57M
Non current assets total 2.84M 3.27M 6.40M 4.02M 4.17M
Capital lease obligations - - - 2.31M 1.74M
Long term debt total - - - 2.25M 0.23M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -0.07M -0.08M -0.24M -0.07M
Change to liabilities - - - -0.57M 0.24M
Total cashflows from investing activities -22.47M -0.07M -0.08M -0.24M -0.70M
Net borrowings - -0.21M 2.62M 1.97M -0.58M
Total cash from financing activities 44.55M 30.33M 8.21M 3.94M 11.59M
Change to operating activities - - - 0.11M -0.61M
Net income -26.20M -29.69M -22.63M -17.53M -19.73M
Change in cash 2.59M 14.88M -4.86M -12.83M -6.62M
Begin period cash flow 16.93M 0.83M 5.69M 18.52M 25.14M
End period cash flow 19.52M 15.71M 0.83M 5.69M 18.52M
Total cash from operating activities -19.75M -15.57M -12.98M -16.82M -17.49M
Issuance of capital stock - 32.91M 5.85M 4.37M 12.17M
Depreciation 1.03M 0.92M 1.30M 0.71M 0.69M
Other cashflows from investing activities -22.02M 0.00M - 0.00M -0.07M
Change to inventory -0.13M 0.45M -0.92M -0.44M -0.18M
Change to account receivables 0.16M 0.07M -0.22M -0.07M 0.15M
Sale purchase of stock -1.36M -1.91M -0.09M -0.07M 12.17M
Other cashflows from financing activities - 31.00M -0.17M 0.51M -0.58M
Change to netincome - - - 1.01M 1.94M
Capital expenditures 0.45M 0.08M 0.08M 0.24M 0.63M
Change in working capital -0.10M 1.20M 2.87M -0.98M -0.39M
Stock based compensation - 0.07M - - -
Other non cash items 5.53M 12.92M 6.78M 16.82M 19.04M
Free cash flow -20.20M -15.65M -13.06M -17.06M -18.11M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
IMR
Imricor Medical Systems Inc		 -0.03
2.29%		 1.28 - - 36401.21 17.45 4019.33 -2.60
COH
Cochlear Ltd		 1.03
0.67%		 155.47 68.64 27.40 4.30 5.34 3.97 28.09
AVR
Anteris Technologies Global Corp		 -0.36
4.21%		 8.20 - - 356.02 2.19 130.34 -5.20
AVH
Avita Medical Inc		 -0.08
1.73%		 4.55 - 9.97 9.59 7.17 6.76 15.37
PNV
Polynovo Ltd		 -0.01
1.66%		 0.89 90.50 90.91 4.17 6.67 4.08 54.57

Profile*

Imricor Medical Systems Inc

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company's products include Vision-MR Ablation Catheter 2.0, a MR-compatible cardiac ablation catheter; Vision-MR Diagnostic Catheter, a MR-compatible diagnostic catheter; NorthStar mapping system, a real-time, high-resolution soft tissue imaging of MRI to guide and visualize procedures with exceptional clarity; and Advantage-MR EP Recorder / Stimulator. The company through its Imricor Cardiovascular vertical provides integrated single session workflows for hospitals for MR imaging. It also offers Vision-MR Dispersive Electrode to minimize eddy currents induced on the device's conductive pads during MR scanning. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.

400 Gateway Boulevard, Burnsville, MN, United States, 55337

952 818 8400

https://www.imricor.com

Name Title Year Born
Mr. Steve Wedan Pres, CEO & Exec. Chairman 1969
Mr. Gregg Stenzel Chief Operating Officer NA
Mr. Jonathon Gut CFO, Controller, Director & VP of Fin. NA
Mr. Greg Englehardt Exec. Director of Sales NA
Mr. Nick Twohy VP of Marketing & Bus. Devel. NA
Mr. Kobe Lizheng Company Sec. & Local Agent NA
Mr. Steve Wedan President, CEO & Executive Chairman 1969
Mr. Jonathon Gut CFO, Controller, Director & VP of Finance NA
Mr. Greg Englehardt Senior Director of Sales NA
Mr. Steve Wedan President, CEO & Executive Chairman 1969

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…